ANSIVEX Trademark

Trademark Overview


On Monday, March 9, 2009, a trademark application was filed for ANSIVEX with the United States Patent and Trademark Office. The USPTO has given the ANSIVEX trademark a serial number of 77686317. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, September 11, 2009. This trademark is owned by Pfizer Inc.. The ANSIVEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, HIV/AIDS, Alzheimer's Disease and Huntington's Disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
ansivex

General Information


Serial Number77686317
Word MarkANSIVEX
Filing DateMonday, March 9, 2009
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, September 11, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2009

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, HIV/AIDS, Alzheimer's Disease and Huntington's Disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, September 11, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, September 11, 2009ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Friday, September 11, 2009ABANDONMENT - AFTER PUBLICATION
Tuesday, August 25, 2009TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, June 23, 2009PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2009NOTICE OF PUBLICATION
Thursday, May 21, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 21, 2009ASSIGNED TO LIE
Thursday, May 21, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 11, 2009ASSIGNED TO EXAMINER
Monday, March 16, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 12, 2009NEW APPLICATION ENTERED IN TRAM